Macrolide Pharmaceuticals Secures $22,000,000 Series A Funding

  • Feed Type
  • Date
    3/5/2015
  • Company Name
    Macrolide Pharmaceuticals
  • Mailing Address
    3 Newton Executive Park Newton, MA 02462 USA
  • Company Description
    Macrolide Pharmaceuticals, LLC. is a new anti-infective company founded to advance groundbreaking technology developed by Professor Andrew Myers of Harvard University.
  • Website
    http://www.macrolidepharma.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $22,000,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    Proceeds of the financing will enable Macrolide Pharmaceuticals to expand its proprietary drug discovery platform and accelerate the development of a pipeline of novel antibiotics.
  • M&A Terms
  • Venture Investor
  • Venture Investor
  • Venture Investor

Trending on Xconomy